Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Am J Med. 2013 Jun 10;126(8):665–669. doi: 10.1016/j.amjmed.2013.02.014

Table 2.

Antibiotics Used for Patients in Re-Treatment Trials of Lyme Disease

Study authors (Reference) Antibiotic inclusion criteria Antibiotic exclusion criteria Past use of antibiotics Antibiotic use in the clinical trial
Klempner et al. (1) Must have received a course of antibiotics for Lyme disease Allergy; ≥60 days of parenteral antibiotics 33% prior IV antibiotics for mean of 30 days; median duration of prior total antibiotic use >50 days Ceftriaxone 2 g IV/day × 30 days followed by doxycycline 100 mg twice daily × 60 days
Krupp et al. (3) Must have been treated for Lyme disease with ≥3 weeks of oral or IV antibiotics Allergy 47.3% prior IV ceftriaxone for ≥3 weeks; mean duration of prior total antibiotic use >50 days Ceftriaxone 2 g IV/day × 28 days
Fallon et al. (4) Must have been treated for Lyme disease with ≥3 weeks of ceftriaxone completed ≥4 months before study entry Allergy 100% prior IV antibiotics for a mean of 69 days plus a mean of 216 days of oral antibiotics Ceftriaxone 2 g IV/day × 70 days